On February 15, 2017, the 24th participant was enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. The new participant was enrolled at the Boulder, Colorado, study site led by Principal Investigator Marcela Ot’alora, M.A., L.P.C. Michael Mithoefer, M.D., and Ann Mithoefer, B.S.N., are serving as Principal Investigators at the site in Charleston, South Carolina. Enrollment in this study is limited by invitation only to therapists in training to work on MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for PTSD. This study has currently enrolled 24 out of 100 participants across the study sites in Colorado and South Carolina. Learn more…
